Arietta.ai
Simon Cottle is a founding partner at Stanley Capital, a mid-market private equity firm specializing in sustainable investments in Resource Efficiency and Healthcare since June 2019. Cottle serves as an investor and board director at Roboyo, which focuses on implementing AI-powered automation technologies for corporates, and is also an investor in Laboratoire XO, a pharmaceutical company, and OpenDialog AI, a conversational AI platform. Additional roles include board membership at Cognition and Qinecsa Solutions, both tech-driven companies, alongside investments in Fintecture, an API gateway for payments, and HeidiPay, a fintech startup enhancing customer engagement in the luxury sector. Past experience includes co-leading a buyout of Essential Pharma as an investor. Cottle holds an MBA from INSEAD and an MA from the University of Oxford.
This person is not in any teams
This person is not in any offices
Arietta.ai
1 followers
At Arietta.ai, we empower our customers to achieve brilliant innovation. We are committed to delivering responsible AI-powered solutions that accelerate quality medical decision-making and data insights. Our passion lies in merging cutting-edge artificial intelligence (AI) technologies with a profound understanding of healthcare, driving us to create a healthier world through the convergence of data, innovation, and insight.